His primary areas of study are Internal medicine, Pediatrics, Parkinsonism, Central nervous system disease and Pathology. His Internal medicine study incorporates themes from Gastroenterology and Endocrinology. His research integrates issues of Surgery, Retrospective cohort study, Dyskinesia and Incidence in his study of Pediatrics.
The Dyskinesia study combines topics in areas such as Levodopa, Meta-analysis and Neurological disorder. Effective treatment is closely connected to Psychiatry in his research, which is encompassed under the umbrella topic of Parkinsonism. J. Eric Ahlskog has included themes like Depression and Cardiology in his Central nervous system disease study.
J. Eric Ahlskog mainly focuses on Internal medicine, Parkinson's disease, Parkinsonism, Pediatrics and Surgery. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology. J. Eric Ahlskog is interested in Levodopa, which is a field of Parkinson's disease.
His work deals with themes such as Movement disorders, Retrospective cohort study and Atrophy, which intersect with Parkinsonism. His Pediatrics study integrates concerns from other disciplines, such as Medical record, Psychiatry, Cohort study and Age of onset. In his study, Botulinum toxin is inextricably linked to Dystonia, which falls within the broad field of Surgery.
His primary areas of investigation include Parkinsonism, Pediatrics, Internal medicine, Atrophy and Rochester Epidemiology Project. His Parkinsonism research is within the category of Disease. His studies deal with areas such as Levodopa, Polysomnogram and Medical record as well as Pediatrics.
His research in Levodopa intersects with topics in Botulinum toxin, Trihexyphenidyl, Symptomatic treatment, Dystonia and Physical therapy. His Internal medicine research includes elements of Gastroenterology, EMG abnormality and Dysphagia. His work on Progressive supranuclear palsy as part of general Atrophy study is frequently connected to Autonomic reflex, Autonomic testing and Orthostatic intolerance, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Parkinsonism, Pediatrics, Rochester Epidemiology Project, Pathology and Internal medicine are his primary areas of study. Parkinsonism is the subject of his research, which falls under Disease. His Pediatrics research incorporates elements of Cognitive impairment, Neuropsychology, Tau pathology, Cause of death and Dementia.
His work carried out in the field of Pathology brings together such families of science as Executive dysfunction and Midbrain. His Internal medicine research includes themes of Gastroenterology, Minor allele frequency and Cerebellar ataxia. His research in Cohort study intersects with topics in Relative risk, Levodopa, Dyskinesia, Levodopa-induced dyskinesia and Severity of illness.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
J. Eric Ahlskog;Manfred D. Muenter.
Movement Disorders (2001)
Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging
J. Eric Ahlskog;Yonas E. Geda;Neill R. Graff-Radford;Ronald C. Petersen.
Mayo Clinic Proceedings (2011)
Pathological gambling caused by drugs used to treat Parkinson disease.
M. Leann Dodd;Kevin J. Klos;James H. Bower;Yonas E. Geda.
JAMA Neurology (2005)
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.
Mitsuru Shiba;James H. Bower;Demetrius M. Maraganore;Shannon K. McDonnell.
Movement Disorders (2000)
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
Hulya Apaydin;J. Eric Ahlskog;Joseph E. Parisi;Bradley F. Boeve.
JAMA Neurology (2002)
Does vigorous exercise have a neuroprotective effect in Parkinson disease
J. Eric Ahlskog.
Risk tables for parkinsonism and Parkinson's disease.
Alexis Elbaz;James H Bower;Demetrius M Maraganore;Shannon K McDonnell.
Journal of Clinical Epidemiology (2002)
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease
Dennis W. Dickson;Hiroshige Fujishiro;Anthony DelleDonne;Joshua Menke.
Acta Neuropathologica (2008)
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease.
Timothy G. Lesnick;Spiridon Papapetropoulos;Deborah C. Mash;Jarlath M H Ffrench-Mullen.
PLOS Genetics (2007)
Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990.
K Radhakrishnan;J E Ahlskog;S A Cross;L T Kurland.
JAMA Neurology (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: